IN BRIEF: Arecor Therapeutics delays publication of 2023 results

Fri, 03rd May 2024 18:02

Arecor Therapeutics PLC - West Sussex, England-based biopharmaceutical firm - Delays publication of 2023 results, which were due to be published Tuesday next week. Says its auditor, Grant Thornton UK LLP, requires more time to complete procedures. Says it will now announce its results in the week commencing May 13.

Current stock price: 137.84 pence

12-month change: down 49%

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Related Shares

More News

14 Jun 2024 19:47

EARNINGS AND TRADING: Sound Energy sells part of Moroccan assets

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...

10 Jun 2024 16:56

LONDON MARKET CLOSE: Political turmoil hits euro and banks

(Alliance News) - Stock prices in Europe ended lower, starting the week on the back foot ahead of a US inflation reading and Federal Reserve decision,...

10 Jun 2024 12:06

LONDON MARKET MIDDAY: Europe heads lower amid political turmoil in EU

(Alliance News) - Stock prices in London were lower at midday Monday, along with the rest of Europe, as investors digest uncertainty from the latest E...

10 Jun 2024 10:32

AIM WINNERS & LOSERS: Arecor Therapeutics dives on funding needs

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

10 Jun 2024 09:54

Arecor Therapeutics shares dive as says needs funding in third quarter

(Alliance News) - Arecor Therapeutics PLC on Monday said it now expects to require new funding in the third quarter of this year.